333 related articles for article (PubMed ID: 9808558)
21. Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor.
Miller JS; Alley KA; McGlave P
Blood; 1994 May; 83(9):2594-601. PubMed ID: 7513206
[TBL] [Abstract][Full Text] [Related]
22. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
[TBL] [Abstract][Full Text] [Related]
23. NK cells differentiated from bone marrow, cord blood and peripheral blood stem cells exhibit similar phenotype and functions.
Carayol G; Robin C; Bourhis JH; Bennaceur-Griscelli A; Chouaib S; Coulombel L; Caignard A
Eur J Immunol; 1998 Jun; 28(6):1991-2002. PubMed ID: 9645381
[TBL] [Abstract][Full Text] [Related]
24. T-cell factor-1 expression during human natural killer cell development and in circulating CD56(+) bright natural killer cells.
Toor AA; Lund TC; Miller JS
Exp Hematol; 2001 Apr; 29(4):499-506. PubMed ID: 11301190
[TBL] [Abstract][Full Text] [Related]
25. Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood.
Wei YM; Cao Q; Zhou HY; Xia R; Lan JC; Meng FY; Bai H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1076-81. PubMed ID: 16403284
[TBL] [Abstract][Full Text] [Related]
26. Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.
Borge OJ; Ramsfjell V; Cui L; Jacobsen SE
Blood; 1997 Sep; 90(6):2282-92. PubMed ID: 9310479
[TBL] [Abstract][Full Text] [Related]
27. Zinc improves the development of human CD34+ cell progenitors towards Natural Killer cells and induces the expression of GATA-3 transcription factor.
Muzzioli M; Stecconi R; Donnini A; Re F; Provinciali M
Int J Biochem Cell Biol; 2007; 39(5):955-65. PubMed ID: 17306601
[TBL] [Abstract][Full Text] [Related]
28. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.
Bennaceur-Griscelli A; Tourino C; Izac B; Vainchenker W; Coulombel L
Blood; 1999 Jul; 94(2):529-38. PubMed ID: 10397720
[TBL] [Abstract][Full Text] [Related]
29. Orderly process of sequential cytokine stimulation is required for activation and maximal proliferation of primitive human bone marrow CD34+ hematopoietic progenitor cells residing in G0.
Ladd AC; Pyatt R; Gothot A; Rice S; McMahel J; Traycoff CM; Srour EF
Blood; 1997 Jul; 90(2):658-68. PubMed ID: 9226166
[TBL] [Abstract][Full Text] [Related]
30. CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo.
Young JC; Lin K; Hansteen G; Travis M; Murray LJ; Jaing L; Scollay R; Hill BL
Exp Hematol; 1999 Jun; 27(6):994-1003. PubMed ID: 10378888
[TBL] [Abstract][Full Text] [Related]
31. Flt3high and Flt3low CD34+ progenitor cells isolated from human bone marrow are functionally distinct.
Gotze KS; Ramirez M; Tabor K; Small D; Matthews W; Civin CI
Blood; 1998 Mar; 91(6):1947-58. PubMed ID: 9490677
[TBL] [Abstract][Full Text] [Related]
32. Lymphokine requirement for the generation of natural killer cells from CD34+ hematopoietic progenitor cells.
Shibuya A; Nagayoshi K; Nakamura K; Nakauchi H
Blood; 1995 Jun; 85(12):3538-46. PubMed ID: 7540065
[TBL] [Abstract][Full Text] [Related]
33. Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency X1 bone marrow cells.
Cavazzana-Calvo M; Hacein-Bey S; de Saint Basile G; De Coene C; Selz F; Le Deist F; Fischer A
Blood; 1996 Nov; 88(10):3901-9. PubMed ID: 8916956
[TBL] [Abstract][Full Text] [Related]
34. Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.
Petzer AL; Zandstra PW; Piret JM; Eaves CJ
J Exp Med; 1996 Jun; 183(6):2551-8. PubMed ID: 8676076
[TBL] [Abstract][Full Text] [Related]
35. Bidirectional effect of interleukin-10 on early murine B-cell development: stimulation of flt3-ligand plus interleukin-7-dependent generation of CD19(-) ProB cells from uncommitted bone marrow progenitor cells and growth inhibition of CD19(+) ProB cells.
Veiby OP; Borge OJ; Mârtensson A; Beck EX; Schade AE; Grzegorzewski K; Lyman SD; Mârtensson IL; Jacobsen SE
Blood; 1997 Dec; 90(11):4321-31. PubMed ID: 9373243
[TBL] [Abstract][Full Text] [Related]
36. The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture.
Miller JS; Verfaillie C; McGlave P
Blood; 1992 Nov; 80(9):2182-7. PubMed ID: 1384796
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the stage in natural killer cell development in 14.5-day mouse fetal liver using adult bone marrow stroma.
Lu J; Patrene KD; Appasamy PM; Herberman RB; Boggs SS
Exp Hematol; 1999 Jun; 27(6):1046-56. PubMed ID: 10378894
[TBL] [Abstract][Full Text] [Related]
38. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.
Huntington ND; Legrand N; Alves NL; Jaron B; Weijer K; Plet A; Corcuff E; Mortier E; Jacques Y; Spits H; Di Santo JP
J Exp Med; 2009 Jan; 206(1):25-34. PubMed ID: 19103877
[TBL] [Abstract][Full Text] [Related]
39. Role of CD95/Fas and its ligand in the regulation of the growth of human CD34(++)CD38(-) fetal liver cells.
Bárcena A; Muench MO; Song KS; Ohkubo T; Harrison MR
Exp Hematol; 1999 Sep; 27(9):1428-39. PubMed ID: 10480434
[TBL] [Abstract][Full Text] [Related]
40. Fibroblasts from human spleen regulate NK cell differentiation from blood CD34(+) progenitors via cell surface IL-15.
Briard D; Brouty-Boyé D; Azzarone B; Jasmin C
J Immunol; 2002 May; 168(9):4326-32. PubMed ID: 11970974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
